● COVID-19
-
SARS-CoV-2 furuwenza A furuwenza B Nucleic Acid Yakasanganiswa
Iyi kit inokodzera in vitro qualitative kutariswa kweSARS-CoV-2, furuwenza A uye furuwenza B nucleic acid ye nasopharyngeal swab uye oropharyngeal swab samples ndeipi yevanhu vaifungidzirwa hutachiona hweSARS-CoV-2, furuwenza A uye furuwenza. B.
-
SARS-CoV-2 Variants
Iyi kit inoitirwa in vitro qualitative yekuona yenovel coronavirus (SARS- CoV-2) mune nasopharyngeal uye oropharyngeal swab samples.RNA kubva kuSARS-CoV-2 inowanzo onekwa mumienzaniso yekufema panguva yakaoma chikamu chetachiona kana asymptomatic vanhu.Inogona kushandiswa kuwedzera kucherechedzwa kwemhando uye kusiyanisa kweAlfa, Beta, Gamma, Delta uye Omicron.
-
Real-time fluorescent RT-PCR kit yekuona SARS-CoV-2
Kiti iyi inoitirwa kuti in vitro inyatso kuona iyo ORF1ab neN gene yenovel coronavirus (SARS-CoV-2) mu nasopharyngeal swab uye oropharyngeal swab inounganidzwa kubva mumatambudziko uye akaungana anofungidzirwa kuti ane novel coronavirus-infected pneumonia nezvimwe zvinodiwa pakuongororwa. kana kusiyanisa kuongororwa kweiyo novel coronavirus hutachiona.
